This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Albemarle (ALB) Laps the Stock Market: Here's Why
by Zacks Equity Research
Albemarle (ALB) reachead $116.78 at the closing of the latest trading day, reflecting a +1.78% change compared to its last close.
Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Albemarle (ALB) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Albemarle (ALB) concluded the recent trading session at $122.59, signifying a +1.52% move from its prior day's close.
Is Invesco S&P 500 Equal Weight Materials ETF (RSPM) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPM
Albemarle (ALB) Trims CapEx, Optimizes Costs Amid Market Dynamics
by Zacks Equity Research
Albemarle (ALB) adjusts its course in the lithium value chain, optimizing costs, reducing capital expenditure and emphasizing short-term growth while safeguarding prospects.
Is Albemarle (ALB) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Albemarle (ALB). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Here is What to Know Beyond Why Albemarle Corporation (ALB) is a Trending Stock
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Company News for Jan 18, 2024
by Zacks Equity Research
Companies In The Article Are:TSLA,IBKR,VZ,ALB
The Andersons and Albemarle have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
The Andersons and Albemarle have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Albemarle (ALB) - copy and publish
by Avirup Banerjee
This lithium producer is cheap.
Bear of the Day: Albemarle (ALB) - corrected
by Tracey Ryniec
This lithium producer is cheap.
Bear of the Day: Albemarle (ALB)
by Tracey Ryniec
This lithium producer is cheap.
Albemarle (ALB) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
In the closing of the recent trading day, Albemarle (ALB) stood at $136.58, denoting a +0.55% change from the preceding trading day.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
New Strong Sell Stocks for January 3rd
by Zacks Equity Research
ALB, FIHL and GEO have been added to the Zacks Rank #5 (Strong Sell) List on January 3, 2024.
Albemarle (ALB) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Albemarle (ALB) concluded the recent trading session at $146.89, signifying a +1.67% move from its prior day's close.
Brokers Suggest Investing in Albemarle (ALB): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Albemarle (ALB) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Wall Street Bulls Look Optimistic About Albemarle (ALB): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Albemarle (ALB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
New Strong Sell Stocks for December 7th
by Zacks Equity Research
ALB, CRGY and LOVE have been added to the Zacks Rank #5 (Strong Sell) List on December 7, 2023.
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Albemarle (ALB). This makes it worthwhile to examine what the stock has in store.
Why Is Albemarle (ALB) Down 2.7% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Buy Albemarle (ALB) Ahead of Earnings?
by Zacks Equity Research
Albemarle (ALB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Wall Street Analysts Think Albemarle (ALB) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Albemarle (ALB). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.